WashingtonPost

U.S. funding for a study on the timing of hepatitis B vaccine doses in infants in Guinea-Bissau has sparked confusion and ethics concerns. View original article Contributor: Tobi Raji

Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers. View original article Contributor: Allyson Chiu

A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric patients. View original article Contributor: Mark Johnson

Brooke Rollins drew ridicule on social media after saying a meal could be a “piece of chicken, a piece of broccoli, a corn tortilla and one other thing.” View original article Contributor: Julie Z. Weil

Caregivers in their 60s, 70s and beyond often go through “pre-bereavement” as their loved ones fade, and then face the financial and emotional fallout. View original article Contributor: Shannon Najmabadi

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA offered an accelerated approval path. View original article Contributor: Daniel Gilbert

The extent of the SAMHSA cuts remains unclear but appear to broadly target more than 2,000 grants totaling nearly $2 billion. View original article Contributor: David Ovalle

Two OB/GYNs appointed to an influential federal vaccine advisory panel have criticized vaccination during pregnancy and more broadly. One called the vaccine industry “disgusting.” View original article Contributor: Lena H. Sun

For the first time, the five-year survival rate for all cancers has reached 70 percent, according to a new report from the American Cancer Society. View original article Contributor: Allyson Chiu

Prenuvo promotes full body MRI scans to detect hazardous conditions early. But medical associations say they may cause unnecessary alarm or a false sense of security. View original article Contributor: Peter Whoriskey